sur Biotricity, Inc. (NASDAQ:BTCY)
Biotricity Announces the Launch of Direct-to-Patient Cardiac Screening Service
Biotricity Inc., a TaaS company, has announced its direct-to-consumer program, HeartSecure. This service offers home-based cardiac screening, targeting 127 million Americans at risk for heart disease.
Currently, patients face long wait times and financial barriers for cardiologist screenings. HeartSecure aims to address these issues by combining advanced technology with cardiology expertise.
The CDC reports that around 60% of U.S. adults live with chronic diseases, increasing heart disease risks. With 127 million adults having risk factors, the need for accessible cardiac screenings is critical.
"Biotricity is revolutionizing lives," said Dr. Waqaas Al-Siddiq, CEO. "HeartSecure empowers individuals to take control of their heart health."
The demand for preventative and chronic disease management has surged, especially with a projected shortage of 86,000 physicians by 2036. HeartSecure addresses this need, symbolizing a shift towards proactive, patient-centric healthcare solutions.
R. P.Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Biotricity, Inc.